Belpointe Asset Management’s AXS Cannabis ETF THCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-531
Closed -$11.4K 3610
2023
Q1
$11.4K Hold
531
﹤0.01% 2648
2022
Q4
$13.8K Buy
+531
New +$15.8K ﹤0.01% 2443
2021
Q3
Sell
-615
Closed -$105K 1258
2021
Q2
$105K Buy
+615
New +$108K 0.01% 1111

Other funds holding THCX

Belpointe Asset Management's THCX Position: Q2 2023 in Review

Belpointe Asset Management sold out of AXS Cannabis ETF (THCX) in Q2 2023, closing a stake of 531 shares — an estimated $11.4K sold.

Belpointe Asset Management first reported a position in THCX in Q2 2021 and held it in 3 quarters. The position peaked at $105K in Q2 2021. 27 funds tracked by Wall St. Rank hold THCX as of Q2 2023.

  • Belpointe Asset Management reported no remaining AXS Cannabis ETF position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 531 AXS Cannabis ETF shares in Q2 2023, an estimated $11.4K.
  • Belpointe Asset Management first reported a position in AXS Cannabis ETF in Q2 2021 and held it in 3 quarters.
  • Belpointe Asset Management's AXS Cannabis ETF position peaked at $105K in Q2 2021.
  • 27 funds tracked by Wall St. Rank held AXS Cannabis ETF as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.